Nobivac Ducat

Cats:
Very common
(> 1 animal / 10 animals treated):
Injection site swelling.
Common
(1 to 10 animals / 100 animals
treated):
Elevated temperature.
Rare
(1 to 10 animals / 10,000 animals
treated):
Hypersensitivity reactions (e.g. pruritus,
dyspnoea, vomiting, diarrhoea and collapse
including anaphylaxis).
Lethargy.
Very rare
(< 1 animal /10,000 animals
treated, including isolated
reports):
Injection site pain.
Febrile limping syndrome reactions in kittens.
1
A local swelling (≤ 5 mm), sometimes painful, may be observed at the injection site for one
day post-vaccination.
Elevated body temperature (up to 40 °C) may occur for 1 – 2 days post vaccination.
Sometimes fatal. If such a reaction occurs, appropriate treatment should be administered
without delay.
Lethargy may be observed during the first day after vaccination.
As reported in the literature, febrile limping syndrome reactions in kittens may occur after
the use of any vaccine containing a feline calicivirus component.

Revised: November 2024
AN: 01917/2024
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or its local representative or the national
competent authority via the national reporting system. See the package leaflet for
respective contact details.